假设全球发售于2026年1月12日(星期一)上午八时正(香港时间)或之前成为无条件，则预期H股将于2026 年1月12日(星期一)上午九时正(香港时间)开始在联交所买卖。H股买卖单位为每手100股H股，H股股份 代号为0501。 格隆汇1月9日丨豪威集团(00501.HK)公告，公司全球发售45,800,000股H股，每股H股104.80港元，所得 款项净额46.93亿港元。香港公开发售股份数目占全球发售股份数目10.00%，获认购9.28倍；国际发售 股份数目占全球发售股份90.00%，获认购倍9.73倍。 ...

Group 1 - The core announcement is regarding the public offering price and listing arrangements for the H-shares of the company, which is set at HKD 104.8 per share [2] - The H-shares are intended for subscription by qualified foreign investors, domestic securities firms authorized for overseas securities investment, qualified domestic institutional investors, and other regulatory-compliant investors [2] - The company has completed the filing for its H-share issuance with the China Securities Regulatory Commission, and the listing application has been reviewed by the Hong Kong Stock Exchange [2] Group 2 - The H-shares are expected to be listed and commence trading on the Hong Kong Stock Exchange on January 12, 2026 [3]

Group 1 - The core transaction of Haowei Group on January 8 involved a block trade of 18,500 shares, amounting to 2.1565 million yuan, with a transaction price of 116.57 yuan, representing an 11.60% discount compared to the closing price of the day [1][2] - The buyer and seller of the block trade were both from the same brokerage, CITIC Securities (Shandong) Co., Ltd., located in the Qingdao West Coast New Area [1][2] - Over the past three months, Haowei Group has recorded a total of 8 block trades, with a cumulative transaction amount of 102 million yuan [1] Group 2 - The latest margin financing balance for Haowei Group is 5.072 billion yuan, showing a decrease of 36.2231 million yuan over the past five days, which is a decline of 0.71% [2] - On the same day, Haowei Group's closing price was 131.86 yuan, reflecting an increase of 1.81%, with a turnover rate of 1.68% and a total trading volume of 2.679 billion yuan [1][2] - The net inflow of main funds for the day was 181 million yuan, while the cumulative net outflow over the past five days was 28.7198 million yuan [1]

Macro Dynamics - The Chinese Foreign Ministry warns that Japan's growing nuclear ambitions pose a serious threat to global peace and stability, urging Japan to clarify its stance on nuclear weapons and adhere to international treaties [2] Company Dynamics - Vanke A announces the resignation of its executive vice president, Yu Liang, due to retirement age, effective January 8, 2026 [10] - Moore Threads releases version 1.1 of its open-source distributed training simulation tool, SimuMax, enhancing its capabilities for large model training [11] - Hao Wei Group sets the final price for its H-share issuance at HKD 104.80 per share, expected to be listed on January 12, 2026 [13][14] - Wens Foodstuff Group forecasts a significant decline in net profit for 2025, estimating a drop of 40.73% to 46.12% year-on-year due to falling pig prices despite stable production management [15] - Jinli Permanent Magnet anticipates a substantial increase in net profit for 2025, projecting a growth of 127% to 161% year-on-year, driven by its applications in various industries including new energy vehicles and robotics [16] Market Data - The Shanghai Composite Index fell by 0.07%, while the Shenzhen Component and ChiNext Index dropped by 0.51% and 0.82% respectively, with significant activity in the commercial aerospace sector [7] - As of January 7, the financing balance on the Shanghai Stock Exchange reached CNY 12,982.15 billion, an increase of CNY 123.16 billion from the previous trading day [8] - The Hang Seng Index declined by 1.17%, with technology stocks underperforming, while the semiconductor sector saw gains [9] Regulatory Updates - The Ministry of Commerce emphasizes that companies engaging in foreign investments and technology exports must comply with Chinese laws and regulations, particularly in the context of Meta's acquisition of Manus [3] - The State Administration for Market Regulation addresses potential monopoly risks in the polysilicon market, leading to a significant drop in polysilicon futures prices [12] Urban Development - Guangzhou issues a plan to accelerate the development of advanced manufacturing, aiming to double industrial added value by 2035 and focusing on strategic industry clusters [4]

Group 1 - The core point of the article is that Haowei Group announced a potential downward adjustment of the conversion price for its "Weier Convertible Bonds" due to its stock closing price being below 85% of the current conversion price for ten consecutive trading days as of January 8, 2026 [1] - According to the regulations from the Shanghai Stock Exchange, if the adjustment conditions are triggered, the company will convene a board meeting on the same day to decide whether to adjust the conversion price and will fulfill its information disclosure obligations promptly [1]

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

Core Viewpoint - The company,豪威集团, has announced the final price for its H-share issuance at HKD 104.80 per share, excluding various transaction fees, with the listing on the Hong Kong Stock Exchange scheduled for January 12, 2026 [1] Group 1 - The final price for the H-share issuance is set at HKD 104.80 per share [1] - The issuance does not include a 1% brokerage commission and other minor transaction fees [1] - The expected listing date for the H-shares on the Hong Kong Stock Exchange is January 12, 2026 [1]

智通财经APP讯，豪威集团(603501.SH)发布公告，公司已确定本次H股发行的最终价格为每股104.80港 元(不包括1%经纪佣金、0.0027%香港证券及期货事务监察委员会交易征费、0.00565%香港联交所交易 费及0.00015%香港会计及财务汇报局交易征费)公司本次发行的H股预计于2026年1月12日在香港联交所 主板挂牌并开始上市交易。 ...

| 证券代码：603501 | 证券简称：豪威集团 公告编号：2026-002 | | --- | --- | | 转债代码：113616 | 转债简称：韦尔转债 | 豪威集成电路（集团）股份有限公司 关于"韦尔转债"预计满足转股价格修正条件的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、可转债发行上市概况 （一）"韦尔转债"基本情况 经中国证券监督管理委员会《关于核准上海韦尔半导体股份有限公司公开发 行可转换公司债券的批复》（证监许可[2020]3024 号）核准，公司公开发行 244,000 万元可转换公司债券，共发行 2,440 万张，每张面值 100 元，期限 6 年。经上海 证券交易所"自律监管决定书[2021]24 号"文同意，公司 24.40 亿元可转换公司债 券于 2021 年 1 月 22 日起在上海证券交易所挂牌交易，债券简称"韦尔转债"，债 券代码"113616"。 根据公司《公开发行可转换公司债券募集说明书》（以下简称"《募集说明书》"） 的约定，"韦尔转债"存续时间为 2020 年 ...

| 证券代码：603501 | 证券简称：豪威集团 | 公告编号：2026-003 | | --- | --- | --- | | 转债代码：113616 | 转债简称：韦尔转债 | | 豪威集成电路（集团）股份有限公司 2026年1月9日 1 豪威集成电路（集团）股份有限公司董事会 关于H股公开发行价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 豪威集成电路（集团）股份有限公司（以下简称"公司"）正在进行申请 发行境外上市外资股（H股）并在香港联合交易所有限公司（以下简称"香港 联交所"）主板上市（以下简称"本次发行上市"）的相关工作。 公司本次发行的H股预计于2026年1月12日在香港联交所主板挂牌并开始上 市交易。 本次拟发行的H股股份的认购对象仅限于符合相应条件的境外投资者及依 据中国相关法律法规有权进行境外证券投资管理的境内证券经营机构和合格境 内机构投资者及其他符合监管规定的投资者。因此，本公告仅为A股投资者及 时了解公司本次发行上市的相关信息而作出，并不构成亦不得被视为是对任何 境内个人或实体收购、购 ...